Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions

Recruiting

• Conditions: Neoplasms
• Interventions: Other: Questionnaires

• Registration Number: NCT05907551
• Lead Sponsor: Institut de cancérologie Strasbourg Europe

Brief Summary

Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities. When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and individual susceptibility. Although these dermatological adverse events are rarely serious, they can significantly alter patients' quality of life, and may even necessitate the introduction of curative treatment.

The impact of these side effects can be mitigated by the use of dermo-cosmetic products and aesthetic solutions. However, most of this supportive care is not reimbursed by the health insurance system, representing a source of inequalities in access to healthcare for cancer patients.

Detailed Description

This study aims at establishing, in a cohort of patients with solid tumors, the state of their knowledges, given information and their financial capacities regarding access to dermo-cosmetics and aesthetic solutions, that are used in the attenuation of cancer treatments' side-effects.

Study Timeline

• Study First Submitted: 2023-06-08
• Study First Submitted QC: 2023-06-08
• Study First Posted: 2023-06-18
• Study Start: 2023-07-25
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-21
• Last Update Posted: 2023-08-22
• Primary Completion: 2023-10-25
• Study Completion: 2023-10-25

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 210

Inclusion Criteria

• Age > 18 years
• Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers)
• Patients able to read and understand French
• Patients that has expressed their consent and with signed consent form

Exclusion Criteria

• Minor or patients placed under guardianship or supervision
• Patients unable to read French
• Patients placed under judicial protection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with Head and Neck Cancer	Questionnaires	-
Patients with Breast Cancer	Questionnaires	-
Patients with Nervous System Tumors	Questionnaires	-
Patients with Urological Cancer	Questionnaires	-
Patients with Lung Cancer	Questionnaires	-
Patients with Gynecologic Cancer	Questionnaires	-
Patients with Digestive System Cancer	Questionnaires	-

Primary Outcome Measures

Name	Time	Method
Describe patients' knowledges regarding dermo-cosmetics and aesthetic solutions that can attenuate cutaneous side-effects, nail and hair toxicities induced by anticancer drugs	at inclusion	10 items questionnaires
Describe patients' knowledges regarding cutaneous side-effects, nail and hair toxicities induced by anticancer drugs	at inclusion	4 items questionnaires

Secondary Outcome Measures

Name	Time	Method
Correlate patients' knowledge level depending on tumoral location	at inclusion	Tumoral location as described in medical chart
Correlate patients' knowledge level depending on treatment phase	at inclusion	Type of treatment phase (i.e. neoadjuvant, adjuvant, 1st or 2nd metastatic line) as described in medical chart
Describe patients' socio-economic profile to assess equity regarding access to dermo-cosmetics and aesthetic solutions	at inclusion	11 items questionnaires
Correlate patients' knowledge level depending on received treatment	at inclusion	Type of chemotherapy administered on the day of inclusion as described in medical chart

Trial Locations

Locations (1)

Institut de cancérologie Strasbourg Europe; 🇫🇷 Strasbourg, France